Vanessa Rhoden
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Vanessa Rhoden has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Etienne Nigron
GIP ARRONAX, 1 rue aronnax, CS10112, Saint-Herblain, 44817, France
2 shared publicationsFerid Haddad
Subatech, UMR 6457, IMT Atlantique, CNRS/IN2P3, Nantes Université, 4 rue Alfred Kastler, Nantes, 44307, France; GIP ARRONAX, 1 rue aronnax, CS10112, Saint-Herblain, 44817, France
2 shared publicationsNathalie Michel
Subatech, UMR 6457, IMT Atlantique, CNRS/IN2P3, Nantes Université, 4 rue Alfred Kastler, Nantes, 44307, France
2 shared publicationsThomas Sounalet
Subatech, UMR 6457, IMT Atlantique, CNRS/IN2P3, Nantes Université, 4 rue Alfred Kastler, Nantes, 44307, France
2 shared publicationsArnaud Guertin
Subatech, UMR 6457, IMT Atlantique, CNRS/IN2P3, Nantes Université, 4 rue Alfred Kastler, Nantes, 44307, France
1 shared publication- Arnaud Guertin
Laboratoire SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes, France
1 shared publication
Latest Publications
- Open Access
- 29 June 2026
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 236, 112779
Molecular plating for targetry: proof of concept using natGd(p,x)155Tb cross section measurements
- 29 June 2026
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 236, 112779
Open AccessMolecular plating for targetry: proof of concept using natGd(p,x)155Tb cross section measurements
- Open Access
- 10 April 2026
- Published by Elsevier in SSRN Electronic Journal
Molecular Plating for targetry: proof of concept using natGd(p,x)155Tb cross section measurements
The production of radionuclides for nuclear medicine is crucial for advancements in both diagnosis and therapy. 155Tb stands out as a promising candidate for SPECT imaging and as counterpart of the therapeutic radionuclide 161Tb in a theranostics approach. This work focuses on the gadolinium target fabrication process via molecular plating (MP) and its uses to study the production and identification of activation products when irradiated with proton. A particular attention is devoted on the quality of the produced targets using different analytical techniques. These findings contribute to ongoing efforts to establish reliable production routes for 155Tb. Our results show good agreement with the literature and simulation data, providing new experimental data to the production of 155Tb and other co-products or impurities via the bombardment of natGd targets and the contribution of (p,x) nuclear reactions, thus validating the MP technique for cross section measurements. This paves the way to fabricate enriched lanthanides target to explore extensively the production of radio-lanthanides.
- 10 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessMolecular Plating for targetry: proof of concept using natGd(p,x)155Tb cross section measurements
The production of radionuclides for nuclear medicine is crucial for advancements in both diagnosis and therapy. 155Tb stands out as a promising candidate for SPECT imaging and as counterpart of the therapeutic radionuclide 161Tb in a theranostics approach. This work focuses on the gadolinium target fabrication process via molecular plating (MP) and its uses to study the production and identification of activation products when irradiated with proton. A particular attention is devoted on the quality of the produced targets using different analytical techniques. These findings contribute to ongoing efforts to establish reliable production routes for 155Tb. Our results show good agreement with the literature and simulation data, providing new experimental data to the production of 155Tb and other co-products or impurities via the bombardment of natGd targets and the contribution of (p,x) nuclear reactions, thus validating the MP technique for cross section measurements. This paves the way to fabricate enriched lanthanides target to explore extensively the production of radio-lanthanides.